What a small eczema trial taught us about fulvic acid

Eczema is one of those things that runs in families. I have relatives who have dealt with it since childhood, and I have watched them cycle through creams and pills and diets and doctors, with mixed results at best. So when I first read about a randomised trial that used fulvic acid cream on eczema, it caught my eye — not because we sell a cream (we don't), but because it was the cleanest piece of human evidence I had come across for anything to do with fulvic acid at all.

What they did

The trial was small. Thirty-six people, aged two years and up, all with confirmed eczema. Half of them applied a cream containing 3.5% carbohydrate-derived fulvic acid, twice a day, for four weeks. The other half applied a matched cream — same base, same feel, same instructions — with everything except the fulvic acid in it. Nobody knew which cream they were using. Not the patients, not the doctors doing the assessments.

What they found

Both creams helped. That is honest to say — an emollient cream on angry skin often calms it down on its own, without any active ingredient. Severity dropped in both groups. Redness dropped in both groups.

But the investigators, who did not know which group was which, judged that the overall improvement in the fulvic acid group was significantly better than the improvement in the placebo group. That's the finding that mattered.

Side effects were mild. Some people reported a short burning feeling when they first applied the cream. That went away. Blood tests taken through the study stayed inside normal limits.

What it does not prove

The authors of the study are careful, and I want to be too.

This was a small trial done at one centre. It is one piece of evidence, not a definitive result. It tested a cream, not a jar of resin. And it tested a specific version of fulvic acid — the carbohydrate-derived kind that a South African lab produces — not the fulvic acid you would find in Himalayan Shilajit resin.

None of that makes the finding less real. But it means you should read it as: fulvic acid, applied to human skin under controlled conditions, produced a measurable improvement in a real skin condition, more than a placebo. That is what it shows. It does not show that eating Shilajit cures eczema.

Why we bother telling you this

Because this is the kind of study we look for.

The market for anything Ayurvedic is full of confident claims and short on evidence. When someone actually does a rigorous trial — even a small one — and it lands on the side of the molecule doing something real, it matters. We would rather point you at a study like this and let you draw your own conclusions than dress up the same finding in language that promises the moon.

The molecule that mattered in that trial is the same molecule that dominates a jar of good Shilajit resin. What it does inside the body, at oral doses, in different conditions — those are separate questions and separate studies. Some have been done. Most have not. When they are, we will point you at those too.

References

• •Gandy JJ, Snyman JR, van Rensburg CEJ. A randomised, parallel-group, double-blind, controlled study to evaluate the efficacy and safety of carbohydrate-derived fulvic acid in topical treatment of eczema. Clinical, Cosmetic and Investigational Dermatology, 2011.